Project title: APPARATUS AND METHOD FOR COLLECTING CORD BLOOD

Company name : SITUGEN LTD.

TECHNOLOGICAL FIELD
Health Care, Medical Devices

KEY WORDS
Umbilical Cord Blood,
Stem Cell Therapy

PROJECT SUMMARY
There is a great clinical need for CBSC (Cord Blood Stem Cell)
therapy as it has been demonstrated to be superior in almost all
parameters compared to Bone Marrow Stem Cells (BMSC). Moreover,
while BMSC can be used only for treating hematological disorders,
CBSC can be applied towards the treatment of over 80 different
diseases and disorders.
SituGen - a disposable kit for CBSC collection designed to solve
the quantity problem and maximize the number of stem cells and
volume of umbilical cord blood collected. The product does not
employ a needle, hence does not create a flow bottleneck; It is
fully disinfected and sterilized, a "must" for all collection
devices.

ENTREPRENEUR
Mr. Miki Shacham - CEO, B.Sc. in
Engineering, MBA from Tel Aviv University, wide experience in
entrepreneurship, management, marketing and R&D.

PROJECT STATUS
The project started its incubator period in October 2006. A
prototype for in-vivo testing of SituGen is under development.
Proof-of-concept is expected in the first half of 2007.
BUDGET: The company has raised US550K$ from the Israeli OCS and
Rad Biomed Incubator.

COOPERATION REQUIRED
The Company is looking for a strategic partnership.
------------------------------------------------
TEL: 972-3-7684945; FAX: 972-3-7684941; E-MAIL:
miki@situgen.com

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about